Fibre-optic probe to fight cancer:
This article was originally published in Clinica
Executive Summary
UK researchers have developed a fibre-optic probe which tells doctors which cancers can be treated with radiotherapy and which will resist. The £17,000 ($27,000) device, called Oxylite, measures the amount of oxygen in a tumour - the more oxygen present, the easier it is to kill the tumour with radiotherapy. The researchers, from the Cancer Research Campaign Advanced Technology Group in London, said the device has wider applications in plastic surgery, head injuries, shock and heart treatments.